Cleton FJ - Search Results

1

Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study.

Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. Eur J Cancer. 2004 Jul;40(11):1713-23. doi: 10.1016/j.ejca.2004.02.029. Eur J Cancer. 2004. PMID: 15251161 Clinical Trial.

2

Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies.

Pauwels EK, Sturm EJ, Bombardieri E, Cleton FJ, Stokkel MP. Pauwels EK, et al. Among authors: cleton fj. J Cancer Res Clin Oncol. 2000 Oct;126(10):549-59. doi: 10.1007/pl00008465. J Cancer Res Clin Oncol. 2000. PMID: 11043392 Review.

3

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.

Weijl NI, Rutten MF, Zwinderman AH, Keizer HJ, Nooy MA, Rosendaal FR, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. J Clin Oncol. 2000 May;18(10):2169-78. doi: 10.1200/JCO.2000.18.10.2169. J Clin Oncol. 2000. PMID: 10811682 Review.

4

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line.

Osanto S, Schiphorst PP, Weijl NI, Dijkstra N, Van Wees A, Brouwenstein N, Vaessen N, Van Krieken JH, Hermans J, Cleton FJ, Schrier PI. Osanto S, et al. Among authors: cleton fj. Hum Gene Ther. 2000 Mar 20;11(5):739-50. doi: 10.1089/10430340050015635. Hum Gene Ther. 2000. PMID: 10757353 Clinical Trial.

5

[Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate].

van Veelen LR, Steyerberg EW, Cleton FJ, Keizer HJ. van Veelen LR, et al. Among authors: cleton fj. Ned Tijdschr Geneeskd. 1999 Mar 13;143(11):564-8. Ned Tijdschr Geneeskd. 1999. PMID: 10321275 Dutch.

6

Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients.

Weijl NI, Hopman GD, Wipkink-Bakker A, Lentjes EG, Berger HM, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. Ann Oncol. 1998 Dec;9(12):1331-7. doi: 10.1023/a:1008407014084. Ann Oncol. 1998. PMID: 9932164 Free article. Clinical Trial.

7

Free radicals and antioxidants in chemotherapy-induced toxicity.

Weijl NI, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. Cancer Treat Rev. 1997 Jul;23(4):209-40. doi: 10.1016/s0305-7372(97)90012-8. Cancer Treat Rev. 1997. PMID: 9377594 Review. No abstract available.

8

Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?

van Holten-Verzantvoort AT, Hermans J, Beex LV, Blijham G, Cleton FJ, van Eck-Smit BC, Sleeboom HP, Papapoulos SE. van Holten-Verzantvoort AT, et al. Among authors: cleton fj. Eur J Cancer. 1996 Mar;32A(3):450-4. doi: 10.1016/0959-8049(95)00564-1. Eur J Cancer. 1996. PMID: 8814691 Free article. Clinical Trial.

9

The diagnostic utility of somatostatin receptor scintigraphy in oncology.

Valkema R, Steens J, Cleton FJ, Pauwels EK. Valkema R, et al. Among authors: cleton fj. J Cancer Res Clin Oncol. 1996;122(9):513-32. doi: 10.1007/BF01213548. J Cancer Res Clin Oncol. 1996. PMID: 8781566 Review.

10

Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma.

van Laar JM, van Buchem MA, Weyl N, Cleton FJ. van Laar JM, et al. Among authors: cleton fj. Eur J Cancer. 1995 Oct;31A(11):1895-7. doi: 10.1016/0959-8049(95)00297-v. Eur J Cancer. 1995. PMID: 8541128 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page